Figure S6 from A Synthetic CD8α:MyD88 Coreceptor Enhances CD8+ T-cell Responses to Weakly Immunogenic and Lowly Expressed Tumor Antigens
Year: 2023
Type: other
Abstract: These data demonstrate that neither checkpoint blockade using anti-PD-L1 or costimulation using anti-4-1BB antibodies enhance pmel CD8a:MyD88 T cells antitumor activity
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4361235949
